Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.

导出 OA

翻译打印收藏纠错

第一作者： Gypsyamber,D'Souza

第一单位： Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA.

作者： Gypsyamber,D'Souza ^[1] ; Sakshi R,Tewari ^[2] ; Tanya,Troy ^[1] ; Tim,Waterboer ^[2] ; Linda,Struijk ^[1] ; Rachel,Castillo ^[2] ; Hannah,Wright ^[3] ; Michael,Shen ^[4] ; Brett,Miles ^[1] ; Mattias,Johansson ^[2] ; Hilary A,Robbins ^[1] ; Carole,Fakhry ^[2]

作者单位： Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA. ^[1] Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medicine, Baltimore, Maryland, USA. ^[2] Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[3] Viroclinics-DDL Diagnostic Laboratory, Rijswijk, Netherlands. ^[4] Department of Otolaryngology-Head and Neck Surgery, Northwell Health, New York, New York, USA. ^[5] Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France. ^[6]

关键词 antibody biomarker human papillomavirus (HPV)oral sex oropharyngeal cancer (OPC)screening